Figure 2From: Prognostic model for long-term survival of locally advanced non-small-cell lung cancer patients after neoadjuvant radiochemotherapy and resection integrating clinical and histopathologic factorsCross-validated survival curves for patients classified as high and low risk including significant clinical and histopathologic parameters as well as age. The survival difference was significant using the log rank test (p = 0.006).Back to article page